Skip to main content

Table 2 Distribution of burden and specific comorbidities in the population from the Elixhauser index (2005–2016)

From: Impact of comorbidity on the short- and medium-term risk of revision in total hip and knee arthroplasty

 

TKA (n = 49,701)

THA (n = 17,923)

Primary

Revision

Primary

Revision

n

%

n

%

n

%

n

%

Burden of comorbidity

 0 comorbidities

14,548

29.3

528

3.6

6862

38.3

175

2.5

 1 comorbidity

17,479

35.2

585

3.3

6079

33.9

159

2.6

 > =2 comorbidities

17,674

35.6

531

3.0

4982

27.8

130

2.6

Uncomplicated hypertension

26,968

54.3

837

3.1

7972

44.5

209

2.6

Uncomplicated diabetes

7903

15.9

221

2.8

2223

12.4

63

2.8

Obesity

5383

10.8

180

3.3

1235

6.9

46

3.7

Depression

4735

9.5

159

3.4

1160

6.5

33

2.8

Chronic pulmonary disease

4100

8.3

117

2.9

1420

7.9

33

2.3

Hypothyroidism

2928

5.9

93

3.2

746

4.2

16

2.1

Deficiency anemia

1162

2.3

34

2.9

471

2.7

12

2.5

Renal failure

964

1.9

18

1.9

391

2.2

7

1.8

Hypertension with complications

949

1.9

18

1.9

305

1.7

2

0.6

Valvular disease

886

1.8

22

2.5

300

1.7

2

0.7

Rheumatoid arthritis /collagen vascular disease

680

1.4

19

2.8

288

1.6

7

2.4

Other neurological disorders

724

1.5

22

3.0

233

1.3

5

2.1

Liver disease

673

1.4

34

5.1

284

1.6

8

2.8

Congestive heart failure

489

1.0

8

1.6

158

0.9

2

1.2

Peripheral vascular disorders

368

0.7

11

3.0

166

0.9

7

4.2

Solid tumor

226

0.5

3

1.3

100

0.6

2

2.0

Diabetes with complications

227

0.5

13

5.7

64

0.4

NR

NR

Coagulopathy

221

0.4

3

1.4

77

0.4

NR

NR

Blood loss anemia

215

0.4

13

6.1

67

0.4

NR

NR

Fluid and electrolyte disorders

214

0.4

5

2.3

126

0.7

2

1.6

Alcohol abuse

194

0.4

6

3.1

132

0.7

3

2.2

Psychosis

172

0.4

3

1.7

77

0.4

5

6.5

Paralysis

88

0.2

7

8.0

39

0.2

2

5.1

Pulmonary circulation disorders

75

0.2

2

2.7

20

0.1

NR

NR

Lymphoma

38

0.1

1

2.6

16

0.1

1

5.9

Peptic ulcer disease (excluding bleeding)

31

0.1

2

6.5

8

< 0.1

NR

NR

Drug abuse

12

< 0.1

NR

NR

28

0.2

NR

NR

Metastatic cancer

10

< 0.1

NR

NR

10

0.1

1

10.0

Weight loss

10

< 0.1

1

10.0

9

0.1

NR

NR

AIDS

4

< 0.1

NR

NR

16

0.1

1

5.9

  1. THA Total Hip Arthroplasty, TKA Total Knee Arthroplasty
  2. n: total number of patients in primary or revision THA or TKA during the study period (2005–2016)
  3. %: percentage of patients
Back to article page

BMC Musculoskeletal Disorders

ISSN: 1471-2474

Contact us